drugset / Trial / NCT04156464

Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit

NCT04156464

Phase 4 Unknown 142 enrolled OSF Healthcare System
RandomizedParallel-groupOpen-labelTreatment

Summary

Our aim is to compare outcomes of patients with benzodiazepine-refractory alcohol withdrawal syndrome who are treated with either a phenobarbital-based or a lorazepam based protocol.

Timeline

Start
2020-07-06
Primary completion
2021-12-01
Completion
2022-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lorazepam Small molecule 4 mg Intravenous
Comparator Phenobarbital Unknown 32.4 mg Intravenous